Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of SITAGAVIA vs Januvia (sitagliptin 100 mg) in healthy adults under fasting conditions
TCTR20231101008Phase 1Unknown
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin (2 arms), sponsored by Government Pharmaceutical Organization. Status: unknown.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20231101008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231101008.